Fiduciary Trust Co grew its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 11.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 3,143 shares of the financial services provider’s stock after acquiring an additional 311 shares during the quarter. Fiduciary Trust Co’s holdings in CME Group were worth $730,000 as of its most recent SEC filing.
A number of other institutional investors have also recently modified their holdings of the stock. New Age Alpha Advisors LLC boosted its position in shares of CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 43 shares in the last quarter. Avidian Wealth Enterprises LLC boosted its holdings in CME Group by 2.6% in the fourth quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider’s stock worth $411,000 after acquiring an additional 45 shares in the last quarter. TFC Financial Management Inc. boosted its holdings in CME Group by 8.4% in the fourth quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider’s stock worth $137,000 after acquiring an additional 46 shares in the last quarter. Waldron Private Wealth LLC boosted its holdings in CME Group by 2.0% in the fourth quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider’s stock worth $549,000 after acquiring an additional 47 shares in the last quarter. Finally, Venturi Wealth Management LLC boosted its holdings in CME Group by 12.1% in the fourth quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider’s stock worth $101,000 after acquiring an additional 47 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several research analysts have issued reports on the company. Barclays increased their price target on CME Group from $279.00 to $283.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 23rd. Raymond James upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target on the stock in a report on Monday, March 10th. JPMorgan Chase & Co. cut their price target on CME Group from $223.00 to $211.00 and set an “underweight” rating on the stock in a report on Thursday, April 24th. Piper Sandler increased their price target on CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a report on Tuesday, April 8th. Finally, Keefe, Bruyette & Woods increased their price objective on CME Group from $265.00 to $273.00 and gave the stock a “market perform” rating in a research note on Thursday, April 24th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and an average price target of $256.80.
CME Group Stock Performance
Shares of CME Group stock opened at $284.35 on Monday. The business’s fifty day simple moving average is $264.47 and its 200 day simple moving average is $245.78. The firm has a market capitalization of $102.47 billion, a P/E ratio of 29.41, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $287.36. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.
CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. CME Group’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period last year, the company posted $2.50 earnings per share. As a group, analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be issued a dividend of $1.25 per share. The ex-dividend date of this dividend is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.76%. CME Group’s dividend payout ratio (DPR) is currently 50.30%.
Insider Buying and Selling
In other CME Group news, Director Dennis Suskind sold 1,000 shares of the business’s stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total value of $271,280.00. Following the sale, the director now directly owns 2,915 shares in the company, valued at $790,781.20. The trade was a 25.54% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Derek Sammann sold 4,650 shares of the business’s stock in a transaction on Monday, May 5th. The shares were sold at an average price of $280.61, for a total value of $1,304,836.50. Following the completion of the sale, the insider now owns 8,336 shares in the company, valued at approximately $2,339,164.96. The trade was a 35.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 34,726 shares of company stock worth $8,975,813. 0.30% of the stock is owned by company insiders.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Constellation Powers Up With Reinforced AI Data Center Strategy
- ESG Stocks, What Investors Should Know
- Top Analyst-Rated Healthcare Stocks to Watch Now
- Insider Selling Explained: Can it Inform Your Investing Choices?
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.